Screening Magnetic Resonance Imaging Recommendations and Outcomes in Patients at High Risk for Breast Cancer

Por Ehsani, Sima, Strigel, Roberta M, Pettke, Erica, Wilke, Lee, Tevaarwerk, Amye J, DeMartini, Wendy, Wisinski, Kari B
Publicado no Breast J (2015)

Phase I Trial of 2-Methoxyestradiol (2ME2, Panzem(®)) NanoCrystal(®) Dispersion (NCD(®)) in Advanced Solid Malignancies

Por Tevaarwerk, Amye J., Holen, Kyle D., Alberti, Dona B., Sidor, Carolyn, Arnott, Jamie, Quon, Check, Wilding, George, Liu, Glenn
Publicado em 2009

Phase 1 study of an AKT-inhibitor (MK-2206) combined with lapatinib in adult solid tumors followed by dose-expansion in advanced HER2+ breast cancer

Por Wisinski, Kari B., Tevaarwerk, Amye J., Burkard, Mark E., Rampurwala, Murtuza, Eickhoff, Jens, Bell, Maria, Kolesar, Jill M., Flynn, Christopher, Liu, Glenn
Publicado no Clin Cancer Res (2016)

Development and Evaluation of a Survey to Assess Survivor Knowledge Change after Survivorship Care Plans: WiSDOM-B (Wisconsin Survey of cancer DiagnOsis and Management in Breast ca...

Por Rocque, Gabrielle B., Wisinski, Kari B., Buhr, Kevin A., Froeschner, Jamie L., Jones, Nathan, Donohue, Sarah, Wiegmann, Douglas, Sesto, Mary E., Tevaarwerk, Amye J.
Publicado em 2014

Potential cytochrome P-450 drug–drug interactions in adults with metastatic solid tumors and effect on eligibility for Phase I clinical trials

Por Wisinski, Kari B., Cantu, Colby A., Eickhoff, Jens, Osterby, Kurt, Tevaarwerk, Amye J., Heideman, Jennifer, Liu, Glenn, Wilding, George, Johnston, Susan, Kolesar, Jill M.
Publicado no Am J Health Syst Pharm (2015)

Breast Cancer Survivor Advocacy at a University Hospital: Development of a peer support program with evaluation by patients, advocates and clinicians

Por Mirrielees, Jennifer A, Breckheimer, Kayla R, White, Terri A, Denure, Deb A, Schroeder, Michele M, Gaines, Martha E, Wilke, Lee G, Tevaarwerk, Amye J
Publicado no J Cancer Educ (2017)

Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles

Por Zasadil, Lauren M., Andersen, Kristen A., Yeum, Dabin, Rocque, Gabrielle B., Wilke, Lee G., Tevaarwerk, Amye J., Raines, Ronald T., Burkard, Mark E., Weaver, Beth A.
Publicado em 2014

Survival in Metastatic Recurrent Breast Cancer after Adjuvant Chemotherapy: Little Evidence for Improvement Over the Past Three Decades

Por Tevaarwerk, Amye J., Gray, Robert, Schneider, Bryan P., Smith, Mary Lou, Wagner, Lynne I., Fetting, John, Davidson, Nancy, Goldstein, Lori, Miller, Kathy D., Sparano, Joseph A.
Publicado em 2012

Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis

Por Valachis, Antonis, Polyzos, Nikolaos P., Coleman, Robert E., Gnant, Michael, Eidtmann, Holger, Brufsky, Adam M., Aft, Rebecca, Tevaarwerk, Amye J., Swenson, Karen, Lind, Pehr, Mauri, Davide
Publicado em 2013

Leveraging Electronic Health Record Systems to Create and Provide Electronic Cancer Survivorship Care Plans: A Pilot Study

Por Tevaarwerk, Amye J., Wisinski, Kari B., Buhr, Kevin A., Njiaju, Ucheanna O., Tun, May, Donohue, Sarah, Sekhon, Navnit, Yen, Thomas, Wiegmann, Douglas A., Sesto, Mary E.
Publicado em 2014

Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score results

Por Andreason, Molly, Zhang, Chong, Onitilo, Adedayo A, Engel, Jessica, Ledesma, Wendy M, Ridolfi, Kimberly, Kim, KyungMann, Charlson, John C, Wisinski, Kari B, Tevaarwerk, Amye J
Publicado no J Community Support Oncol (2015)

Evaluating Primary Care Providers' Views on Survivorship Care Plans Generated by an Electronic Health Record System

Por Donohue, SarahMaria, Sesto, Mary E., Hahn, David L., Buhr, Kevin A., Jacobs, Elizabeth A., Sosman, James M., Andreason, Molly J., Wiegmann, Douglas A., Tevaarwerk, Amye J.
Publicado no J Oncol Pract (2015)

Targeting Estrogen Receptor Beta in a Phase II Study of High Dose Estradiol in Metastatic Triple Negative Breast Cancer: A Wisconsin Oncology Network Study

Por Wisinski, Kari B., Xu, Wei, Tevaarwerk, Amye J., Saha, Sandeep, Kim, KyungMann, Traynor, Anne, Dietrich, Leah, Hegeman, Robert, Patel, Dhimant, Blank, Jules, Harter, Josephine, Burkard, Mark E.
Publicado no Clin Breast Cancer (2016)

Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor–Positive Breast Cancer (E-3193, INT...

Por Tevaarwerk, Amye J., Wang, Molin, Zhao, Fengmin, Fetting, John H., Cella, David, Wagner, Lynne I., Martino, Silvana, Ingle, James N., Sparano, Joseph A., Solin, Lawrence J., Wood, William C., Robert, Nicholas J.
Publicado no J Clin Oncol (2014)

Feasibility of four cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: A Wisconsin Oncology Network Study

Por Burkard, Mark E., Wisinski, Kari B., Njiaju, Uchenna O., Donohue, SarahMaria, Hegeman, Robert, Stella, Amy, Mansky, Patrick, Shah, Varsha, Goggins, Timothy, Qamar, Rubina, Dietrich, Leah, Kim, KyungMann, Traynor, Anne M., Tevaarwerk, Amye J.
Publicado em 2013

Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies

Por Attia, Steven, Morgan-Meadows, Sherry, Holen, Kyle D., Bailey, Howard H., Eickhoff, Jens C., Schelman, William R., Traynor, Anne M., Mulkerin, Daniel L., Campbell, Toby C., McFarland, Thomas A., Huie, Michael S., Cleary, James F., Tevaarwerk, Amye J., Alberti, Dona B., Wilding, George, Liu, Glenn
Publicado em 2008